Participating Faculty: Emerging Evidence in NSAID Pharmacology: Important Considerations for Product Selection

This supplement to The American Journal of Managed Care looks at emerging evidence in NSAID pharmacology, including the relationship between COX selectivity and NSAID dose, the effect of NSAID dosing on adverse events, and pharmacokinetic principles to consider in selecting an NSAID product.This supplement was sponsored by Iroko Pharmaceuticals, LLC.

Faculty

Philip P. Gerbino, PharmD, BSc

President Emeritus

University of the Sciences

Linwood F. Tice Professor Emeritus

Philadelphia College of Pharmacy

Philadelphia, Pennsylvania

Tracy S. Hunter, PhD, MS, BS Pharm

Professor and Director of Continuing Professional Development

Wingate University School of Pharmacy

Wingate, North Carolina

Chip Robison, PharmD, RPh

Regional Coverage Pharmacist

Healix Infusion Therapy

Atlanta, Georgia

Faculty Disclosures

These faculty report relationships with the following organizations:

Philip P. Gerbino, PharmD, BSc

Advisory board: ACRO Pharmaceutical Services

Tracy S. Hunter, PhD, MS, BS Pharm, and Chip Robison, PharmD, RPh, have no relevant financial relationships with commercial interests to disclose.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Download PDF: Participating Faculty: Emerging Evidence in NSAID Pharmacology: Important Considerations for Product Selection